WallStreetZenWallStreetZen

NASDAQ: BCAX
Bicara Therapeutics Inc Stock Ownership - Who owns Bicara Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bicara Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David RabenChief Medical Officer2026-04-275,500$22.88
$125.83kSell
David RabenChief Medical Officer2026-04-275,500$3.79
$20.85kBuy
Ivan HyepChief Financial Officer2026-04-219,200$3.79
$34.87kBuy
Ivan HyepChief Financial Officer2026-04-219,200$23.00
$211.62kSell
Claire MazumdarChief Executive Officer2026-04-2015,000$23.61
$354.15kSell
Claire MazumdarChief Executive Officer2026-04-2015,000$3.79
$56.85kBuy
Claire MazumdarChief Executive Officer2026-04-168,226$4.44
$36.50kBuy
Claire MazumdarChief Executive Officer2026-04-167,454$3.79
$28.25kBuy
Claire MazumdarChief Executive Officer2026-04-167,080$5.45
$38.61kBuy
Ryan CohlheppPresident and COO2026-04-154,500$23.01
$103.53kSell

1 of 11

BCAX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCAX insiders and whales buy or sell their stock.

BCAX Shareholders

What type of owners hold Bicara Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP10.63%6,955,993$152.48MInstitution
Kiran Mazumdarshaw9.62%6,297,854$138.05MInsider
Biocon Ltd8.44%5,523,897$121.08MInsider
Siren LLC7.97%5,216,969$114.36MInstitution
Vestal Point Capital LP5.46%3,575,000$78.36MInstitution
Fmr LLC5.11%3,347,223$73.37MInstitution
T Rowe Price Investment Management Inc4.94%3,236,595$70.95MInstitution
Red Tree Management LLC4.84%3,170,509$69.50MInstitution
Tpg GP A LLC4.60%3,010,425$65.99MInstitution
Ra Capital Management LP4.05%2,652,575$58.14MInsider

1 of 3

BCAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCAX72.96%27.04%Net BuyingNet Buying
BHVN78.77%15.74%Net Buying
VIR69.11%30.89%Net SellingNet Selling
IMCR95.91%4.09%Net SellingNet Selling
KALV62.24%37.76%Net SellingNet Selling
View Top Biotech Stocks

Bicara Therapeutics Stock Ownership FAQ

Who owns Bicara Therapeutics?

Bicara Therapeutics (NASDAQ: BCAX) is owned by 87.20% institutional shareholders, 32.31% Bicara Therapeutics insiders, and 0.00% retail investors. Kiran Mazumdarshaw is the largest individual Bicara Therapeutics shareholder, owning 6.30M shares representing 9.62% of the company. Kiran Mazumdarshaw's Bicara Therapeutics shares are currently valued at $134.02M.

If you're new to stock investing, here's how to buy Bicara Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.